ABT-ABBOTT LABORATORIES

Abbott Laboratories Emerges as a Resilient Investment with Strong Sales Growth and a Solid Dividend History Despite Competitive Pressures

Member Only Article

Monday

24 February, 2025

Abbott Laboratories showcases remarkable resilience with a 10% sales growth and a strong commitment to innovation, particularly in its Medical Device segment. As a "Dividend King" with a solid history of increasing dividends, can Abbott navigate the competitive healthcare landscape while maintaining its growth trajectory?

article image for ABT

Article Impact Score

0
50
100
Under­perform
Bear­ish
Neu­tral
Bull­ish
Out­perform
0
Key Takeaways
  • Loading...

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial
home-footer-logo

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.